Owners, management and financials
CVR: 37663808
DKK -14,828,000
Gross profit
Net result: DKK -13,687,000
Linc AB (10-14,99%), Adrigo Asset Management (5-9,99%)
CVR · view owners
Claus Elsborg Olesen
Board: Gunnar Magnus Severus Modée Persson (chair) and 5 members
CVR · view management
Active
Founded 2 May 2016
CVR · view overview
3 employees
CVR · 2026
Owner registered: Linc AB
CVR · 16/06/2021
View the full event history
Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.
Selskabets formål er at forske, udvikle, producere og sælge lægemidler og lægemiddelkandidater, relaterede teknologier, service og andre beslægtede forretningsområder efter bestyrelsens skøn.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -14.8 mio. | -13.7 mio. | 33.8 mio. | 29.5 mio. | 1 | |
| 202401/01/2024 – 31/12/2024 | -11.1 mio. | -12.9 mio. | 15.8 mio. | 14.8 mio. | 2 | |
| 202301/01/2023 – 31/12/2023 | -23.4 mio. | -22.9 mio. | 29.8 mio. | 11.2 mio. | 2 | |
| 202201/01/2022 – 31/12/2022 | -38.4 mio. | -38.5 mio. | 48.3 mio. | 34 mio. | 3 | |
| 202101/01/2021 – 31/12/2021 | -22 t. | -21 t. | 54 t. | 35 t. | - | |
| 202001/01/2020 – 31/12/2020 | -9.3 mio. | -8.7 mio. | 15.6 mio. | 14.4 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | -8.4 mio. | -8.3 mio. | 11.4 mio. | 9.9 mio. | 1 | |
| 201801/01/2018 – 31/12/2018 | -11.4 mio. | -10.3 mio. | 17.3 mio. | 16.6 mio. | 1 | |
| 201701/01/2017 – 31/12/2017 | -8.2 mio. | -8.6 mio. | 9.3 mio. | 6 mio. | 2 |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Initiator Pharma A/S is 37663808.
Initiator Pharma A/S is owned by Linc AB and Adrigo Asset Management.
The management of Initiator Pharma A/S consists of Claus Elsborg Olesen.
The board of Initiator Pharma A/S consists of Gunnar Magnus Severus Modée Persson, Annette Ingegerd Marie Colin and Claus Elsborg Olesen, with Gunnar Magnus Severus Modée Persson as chair.
In 2025, Initiator Pharma A/S reported a gross profit of DKK -14,828,000.
Initiator Pharma A/S had 3 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
As of September 1, 2026, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of Initiator Pharma A/S.
As of September 1, 2026, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Initiator Pharma A/S.
Initiator Pharma A/S has published its annual report for 2025. Gross profit came to DKK -14,828,000, and the net result was DKK -13,687,000.
As of May 29, 2026, Majken Christina Östberg Lloyd has joined the board of directors of Initiator Pharma A/S.
As of May 29, 2026, Göran Albert Torstensson Ando has left the board of directors of Initiator Pharma A/S.
Initiator Pharma A/S has published its annual report for 2024. Gross profit came to DKK -11,073,000, and the net result was DKK -12,932,000.
As of May 23, 2025, Göran Albert Torstensson Ando has joined the board of directors of Initiator Pharma A/S.
As of May 23, 2025, Henrik Kristian Moltke has left the board of directors of Initiator Pharma A/S.
Initiator Pharma A/S has published its annual report for 2023. Gross profit came to DKK -23,413,000, and the net result was DKK -22,873,000.
Initiator Pharma A/S has published its annual report for 2022. Gross profit came to DKK -38,425,000, and the net result was DKK -38,455,000.
Initiator Pharma A/S has published its annual report for 2021. Gross profit came to DKK -21,626, and the net result was DKK -21,064.
As of May 24, 2022, Ylva Gunilla Ekström has joined the board of directors of Initiator Pharma A/S.
As of June 16, 2021, is registered as an owner of Initiator Pharma A/S with an ownership share of 10%.
As of June 16, 2021, is registered as an owner of Initiator Pharma A/S with an ownership share of 5%.
Initiator Pharma A/S has published its annual report for 2020. Gross profit came to DKK -9,299,000, and the net result was DKK -8,697,000.
As of January 14, 2021, Annette Ingegerd Marie Colin has joined the board of directors of Initiator Pharma A/S.
Initiator Pharma A/S has published its annual report for 2019. Gross profit came to DKK -8,366,000, and the net result was DKK -8,288,000.
Initiator Pharma A/S has published its annual report for 2018. Gross profit came to DKK -11,437,000, and the net result was DKK -10,298,000.
Initiator Pharma A/S has published its annual report for 2017. Gross profit came to DKK -8,180,000, and the net result was DKK -8,582,000.
Initiator Pharma A/S has published its interim report for the period May 2, 2016 – December 31, 2016.
As of January 20, 2017, Claus Elsborg Olesen has joined the board of directors of Initiator Pharma A/S.
As of September 19, 2016, Henrik Kristian Moltke has joined the board of directors of Initiator Pharma A/S.
As of September 19, 2016, Gunnar Magnus Severus Modée Persson has joined the board of directors of Initiator Pharma A/S.
As of September 19, 2016, Peter Joakim Holm has joined the board of directors of Initiator Pharma A/S.
As of September 19, 2016, Claus Elsborg Olesen has left the board of directors of Initiator Pharma A/S.
As of September 19, 2016, Ulf Simonsen has left the board of directors of Initiator Pharma A/S.
As of September 19, 2016, Dan Leif Peters has left the board of directors of Initiator Pharma A/S.
As of May 2, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Initiator Pharma A/S.
As of May 2, 2016, Claus Elsborg Olesen has joined the board of directors of Initiator Pharma A/S.
As of May 2, 2016, Ulf Simonsen has joined the board of directors of Initiator Pharma A/S.
As of May 2, 2016, Dan Leif Peters has joined the board of directors of Initiator Pharma A/S.
As of May 2, 2016, Claus Elsborg Olesen is registered as director of Initiator Pharma A/S.
Initiator Pharma A/S was founded on May 2, 2016.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46543912
CVR 44478587
CVR 31427169
